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Summary
The structural requirements for signal transduction by class I major histocompatibility complex
(MHC) molecules were examined. Native or mutant HLAA2 or HLAB27 constructs lacking
most of theircytoplasmic domains were co-transfected with pSV2neo intoJurkat cells. Transfection
of either native or mutant constructs resulted in a comparable expression of the gene products.
Stimulation of transfectants expressing either native or truncated A2 or B27 molecules with
specific mAb evoked an increase in [Ca2+ ]i upon crosslinking. Moreover, crosslinking native or
truncated A2 or B27 induced IL-2 productionupon co-stimulation with phorbol myristate acetate.
These results confirm that crosslinking class I MHC molecules transduces an activation signal
to human T cells. Effective signaling was observed when all but four of the intracytoplasmic
residues were deleted, indicating that signal transduction does not require this portion of the
molecule.
T
he role of class I MHC molecules in restricting T
cell-mediated cytotoxicity is well established (1). Recently,
a role for class I MHC molecules as signal-transducing struc-
tures on human T cells has also been demonstrated (2, 3).
Thus, crosslinking mAb to monomorphic or polymorphic
determinants of class I MHC molecules expressed by highly
purified humanperipheral blood T cells, Jurkat T cell leukemia
cells, or human T cell clones resulted in an increase in intra-
cellular calcium ([Ca2+]i) and Ilr2 production with appro-
priate co-stimulation. Since certain functions ofclass I MHC
molecules have been shown to require the integrity of the
cytoplasmic domain (4), the present study was carried out
to study the role of the cytoplasmic domain of class I MHC
molecules in signal transduction and activation of T cells.
Wild-type or mutant HLAA2 or HLAB27 genes were trans-
fected into Jurkat cells, and the capacity of the transfected
cells to be activated upon cross-linking with mAb to poly-
morphic determinants encoded by the transfected genes was
examined. Effective T cell signaling was observed when all
but four of the intracytoplasmic residues were deleted, indi-
cating that signal transduction does not require this portion
of the molecule.
mAbs.
￿
A variety of mAbs were used, including: 64.1, directed
at the CD3 molecular complex; W6/32 and MB40.5, directed at
monomorphic MHC class I-encoded gene products; TM-1 (a gift
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from Dr. Elisabeth Weiss, Institute for Immunology, University
ofMunich, Munich, West Germany), directed at an HLA-B27 de-
terminant (5); MA2.1, directed at HLA-A2 or B17 (6); and PA2.1,
directed at an HLAA2 determinant (7). IgG2amAb P1.17 and IgG1
mAb MOPC-31C were used as controls.
DNA Constricts.
￿
Site-directed mutagenesis was carried out as
previouslydescribed (8) on genomic clones encoding HLA-V0201
(the gift of Dr. H.T. Orr, University of Minnesota, Minneapolis,
MN) or HLA-B"2705 . Mutagenesis of HLAA2 was carried out
on a 1.8-kb Bg1II-Sphl fragment containing exons 4-7, subdoned
into M13mp19. Mutagenesis of HLA1327 was carried out on a 2.3-
kb AvrII-Pstl fragment containing exons 4-8, subcloned into
M13mp19. A2 and B27 exon 5 stop codon mutants (A21-312,
B271-312) with a Ser-Asn substitution at position 312 and
Ser-"stop codonat position 313 were constructed. Successfulmuta-
genesis was confirmed by oligonucleotide hybridization followed
by DNA sequencing. The double-stranded mutated inserts were
then isolated and ligated into pUC9 (HLAA2) or pUC19 (HLA-
B27) constructsthat contained the remainder ofthe respectivegenes.
The presence of the correct mutations was confirmed by DNA se-
quencing of the reconstituted plasmids in both orientations.
DNA Transfection.
￿
DNA-mediated gene transfer intoJurkat cells
was accomplished by electroporation. Genes of interest were co-
transfected with pSV2neo and cells were selected for neo gene ex-
pression with G418. In some experiments transfected cells were
cloned before use.
Cell Culture Techniques.
￿
The cells were incubated with saturating
concentrations ofmAbs for 30 min at 4°C, washed, and incubated
in microtiter wells (No. 3596; Costar, Cambridge, MA), with or
without affinity-purified goat anti-mouse Ig (GaMIg, 1 ug/ml)
and PMA (1 ng/ml) for 24 h at 37°C, after which the culture su-
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the use ofCTLL cells, as described (3). All data are calculatedfrom
the mean cpm oftriplicate determinations and areexpressed as U/ml
of IL-2 as compared with a standard curve.
Analysis of Cytosolic Free Calcium ffCa2+]).
￿
Flow cytometry
was performed as described (2) to analyze the change in [Ca2+]i
of the cell populatidn afterloading the cells with the calcium sen-
sitive dye, indo-1.
Results
Expression ofNative or Mutant HLAA2 or HLA-B27 Genes
by TransfectedJurkat Cells. Control Jurkat cells expressed nei-
ther HLA-A2 or HLA-B27 (Fig. 1). Transfection with either
native or truncated genesresulted in expression ofA2 or B27
molecules. Immunoprecipitation of surface iodinated mole-
cules and analysis by PAGE confirmed that the transfectants
expressed class I MHC heavychains of the predicted size and
that the expressed heavy chains were associated with 02-
microglobulin (data not shown).
Crosslinking Native or Mutant Class I MHC Molecules In-
duces a Rise in [Ca2+],. Crosslinking the native or the mu-
tant class I MHC molecules induced an increase in [Ca2+]i.
As shown in Fig. 2, >60% ofJurkat cells expressing either
A2 or truncated A21_312 generated a rapid and sustained in-
crease in [Ca2+]; upon crosslinking with GaMIg. Similar
results were observed with B27 and B271-.312 (data not
shown). By contrast, no change in [Ca2+]; was induced in
control Jurkat cells.
Crosslinking Native or Truncated Class I MHC Molecules In-
duces 11,2 Production. Jurkat cells produce IL2 when CD3
is engaged and the cells are co-stimulated with PMA. Simi-
larly, crosslinking class I MHC molecules and co-stimulating
with PMA induces IIr2 production. Crosslinking native or
truncated A2 induced IIr2 production upon co-stimulation
with PMA (Table 1). Comparable results were observed when
truncated B27 molecules were crosslinked with specific mAbs
(Table 1). In contrast, neither MA2.1 nor TM-1 induced 11,2
production by control Jurkat (data not shown).
CELL
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￿
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Figure 2.
￿
The capacity of wild-type or mutant HLA-A2 molecules to
induce an increase in [Ca2+];. Cells were pretreated with MA2.1, washed,
and analyzed for [C32+] ; . The arrow indicates addition of GaMlg.
The experiments described in this communication were
undertaken to determine the structural requirements for signal
transduction by class I MHC molecules. The results indicate
that the cytoplasmic portion of class I MHC molecules is
not required for signal transduction.
Transfection of Jurkat cells with either the wild-type or
the mutant A2 or B27 constructs resulted in stable cell sur-
face expression of the appropriate molecules. This observa-
tion indicates that no more than four amino acids of the cy-
Table 1 .
￿
Crosslinking Native or Truncated HLA-A2 or B27
Molecules Induces IL-2 Production by Transfected Jurkat Cells
Transfected gene mAb specificity
IL-2
Nil
production
GaMIg
U/ml
A2 Control 0.6 0.6
CD3 6 .1 2.7
HLA-A,B,C 0.5 5.4
HLA-A2 0.5 3.8
A21--312 Control 1 .5 1 .6
CD3 >16.0 15.0
HLA-A2 0.6 6.6
HLA-B27 0.5 0.5
13271-312 Control 0.6 0.5
CD3 >10.0 >10.0
HLA-A,B,C 0.5 >10.0
HLA-1327 0.8 9.2toplasmic domain are required for transport to and stable
expression ofclass I MHC molecules on the cell surface, and
is in accordance with previous observations of normal ex-
pression of truncated H-2Ld molecules transfected into mu-
rine L cells (9).
Normal expression of a variety of other transmembrane
molecules including CD2, CD4, CD3-e and I-A has also been
notedwhen various portions of the cytoplasmic domains were
deleted (10-13). Thus, the cytoplasmic domains of a variety
offunctionally important transmembrane molecules expressed
on lymphoid cells are not required for expression. The cyto-
plasmic portion of the molecule may be important for other
aspects of their function, however. One aspect of the func-
tion of transmembrane molecules that frequently appears to
require the intracytoplasmic domain is the capacity to transmit
activation signals to lymphocytes. This conclusion is supported
by the observations that truncated CD2 and CD4 do not
function as effective signal generatingmolecules (10, 11, 14).
The signaling capacity of class I MHC molecules differed from
that ofCD2 or CD4 in that the cytoplasmic domain did not
appear to be required. These results imply that signal trans-
duction by class I MHC molecules differs from that induced
by engaging CD2 or CD4. Moreover, the results indicate
that signal transduction has different structural requirements
than other functional activities of class I MHC molecules.
For example, constitutive endocytosis ofclass I MHC mole-
cules via coated pits requires residues 323-340 (exon 7) of
the cytoplasmic domain (4). The current results, therefore,
not only imply that different functional activities manifest
different structural requirements, but also that constitutive
References
2.
3.
endocytosis is not required for classI MHC molecules to trans-
duce activation signals.
The cytoplasmic domain of class I MHC undergoes phos-
phorylation, the significance of which is unclear. The major
in vivo site is serine 335, which is conserved between human
and murine molecules (15). In addition, there is a highly con-
served single tyrosine residue in position 320 of the cyto-
plasmic domain (16). The results of the current studies indi-
cate that neither serine nor tyrosine phosphorylation of the
cytoplasmic tail is involved in T cell activation induced by
cross-linking class I MHC molecules.
The current findings do not establish the mechanism by
which class I MHC molecules transduce activation signals.
One possibility is that crosslinking class I MHC molecules
induces association with other cell surface proteins that
transmit activation signals. Since the ability of truncated
H-2Ld molecules to undergo capping is comparable to na-
tive molecules (9), they are likely to retain the capacity to
interact with the cytoskeleton. Such an association might play
a role in establishing a macromolecular complex, including
class I MHC molecules, involved in signal transduction.
In conclusion, the results confirm that crosslinking class
I MHC molecules both induces a rise in (Caz+ji and co-
stimulates Ilr2 production. Deletion of the cytoplasmic por-
tion of the molecule, which includes highly conserved and
seemingly important domains and phosphorylation sites, did
not affect the ability of the mutant constructs to deliver an
activation signal. Class I MHC molecules, therefore, differ
from CD2 and CD4 in which the cytoplasmic domain is re-
quired for signal transduction.
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